An Application of Iterative Health Economic Evaluation: An Update on the Early Cost Effectiveness of Whole-Genome Sequencing in Advanced Non-small-Cell Lung Cancer
Lessons from surgery after neoadjuvant chemoimmunotherapy for bulky, invasive N2 lung cancer: a case report | General Thoracic and Cardiovascular Surgery Cases
Ceralasertib plus durvalumab in Ras mutant and Ras wild type advanced non-small cell lung cancer: Two cohorts of the phase II platform National Lung Matrix Trial
HIV-induced neoantigen immunodeficiency: a novel mechanism of immune evasion in non-small cell lung cancer and implications for next-generation immunotherapies | Journal of Translational Medicine